Arcoma AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
04-25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01-29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 183M 17.28M 0 23.63M | Sales 2025 * | 199M 18.79M 0 25.7M | Capitalization | 204M 19.3M 0 26.39M |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.32M - 1.81M | Net income 2025 * | 16M 1.51M - 2.07M | EV / Sales 2024 * | 1.08 x |
Net cash position 2024 * | 7M 661K 0 904K | Net cash position 2025 * | 19M 1.79M 0 2.45M | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
12.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 53 | 93-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-12-31 | |
Director/Board Member | 53 | 10-02-28 | |
Lars Kvarnhem
CHM | Chairman | 52 | 16-12-31 |
1st Jan change | Capi. | |
---|---|---|
-8.74% | 14.14B | |
-45.12% | 2.51B | |
-18.54% | 2.29B | |
-18.03% | 1.36B | |
-.--% | 1.12B | |
+90.51% | 508M | |
+33.28% | 491M | |
+30.29% | 285M | |
+2.58% | 237M |